DIAGNOS-depose-une-pre-soumission-aupres-de-la-FDA-pour-son-systeme-CARA-Entree-strategique-sur-le-marche-americain-de-loptometrie-avec-le-soutien-dORA-LLC

DIAGNOS-depose-une-pre-soumission-aupres-de-la-FDA-pour-son-systeme-CARA-Entree-strategique-sur-le-marche-americain-de-loptometrie-avec-le-soutien-dORA-LLC